Familial Hypercholesterolemia Screening in a Cardiac Rehabilitation Program After Myocardial Infarction

Familial Hypercholesterolemia Screening in a Cardiac Rehabilitation Program After Myocardial Infarction

Familial hypercholesterolemia (FH) is relatively prevalent in myocardial infarction (MI) sufferers, and its diagnosis could improve preventive treatment in family members. We aim to analyze the diagnosis of FH and the rate of genetic testing in a prospective cohort of 245 patients submitted to our C...

Full description

Saved in:

Bibliographic Details
Main Authors:	Carlos Bertolín-Boronat, Víctor Marcos-Garcés, Héctor Merenciano-González, María Luz Martínez Mas, Josefa Inés Climent Alberola, Nerea Perez, Laura López Bueno, María Concepción Esteban Argente, María Valls Reig, Ana Arizón Benito, Alfonso Payá Rubio, César Ríos-Navarro, Elena de Dios, Jose Gavara, Manuel F. Jiménez-Navarro, Francisco Javier Chorro, Juan Sanchis, Vicente Bodi
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Series:	Cardiogenetics
Subjects:	myocardial infarction familial hypercholesterolemia cardiac rehabilitation genetic testing Dutch Lipid Clinic Network
Online Access:	https://www.mdpi.com/2035-8148/15/1/6
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program
by: Carlos Bertolín-Boronat, et al.
Published: (2025-01-01)

Depression, Anxiety, and Quality of Life in a Cardiac Rehabilitation Program Without Dedicated Mental Health Resources Post-Myocardial Infarction
by: Carlos Bertolín-Boronat, et al.
Published: (2025-03-01)

Prevalence and Prognostic Significance of Familial Hypercholesterolemia among Patients with Premature Coronary Artery Disease Admitted to a Tertiary Care Hospital: A Prospective Observational Study
by: Aditya Bansal, et al.
Published: (2024-10-01)

Familial homozygous hypercholesterolemia with arcus cornea and xanthomas: A rare but serious entity
by: Amal Chamli, et al.
Published: (2023-03-01)

School-based universal screening for hypercholesterolemia in children
by: Chang-Hsien Yu, et al.
Published: (2022-07-01)

Hypercholesterolemia, as a Predictor Factor of Severe Acute Pancreatitis
by: Bogdan Socea, et al.
Published: (2018-12-01)

The Importance of Genetic Testing for Familial Hypercholesterolemia: A Pediatric Pilot Study
by: Andreea Teodora Constantin, et al.
Published: (2024-09-01)

Hypertension and Hypercholesterolemia: is it Time for Anti-«Lipitensive» Therapy?
by: Z. D. Kobalava, et al.
Published: (2020-11-01)

Global scientific trends in hypercholesterolemia research from 2003 to 2023: a data-driven bibliometric and visual analysis
by: Haoxin Guo, et al.
Published: (2025-06-01)

ANTI-HYPERCHOLESTEROLEMIA ACTIVITY OF ETHANOL EXTRACT Peperomia pellucid
by: Chasanah Mazroatul, et al.
Published: (2016-03-01)

Dietary Approach in Familial Hypercholesterolemia
by: Joanna Popiolek-Kalisz, et al.
Published: (2025-01-01)

2024 Polish recommendations for the management of familial hypercholesterolemia in children and adolescents
by: Małgorzata Myśliwiec, et al.
Published: (2024-11-01)

Effectiveness of Food Cholesterol Detect (FCD) Application on Total Cholesterol Levels of Hypercholesterolemia Patients
by: Terati Terati, et al.
Published: (2025-03-01)

DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY)
by: A. I. Ershova, et al.
Published: (2015-09-01)

Monitoring of bone matrix acidification by TRAP and ERK biomarkers in the chronic hypercholesterolemia male rats
by: Duaa Raad Abd-Al-Ameer, et al.
Published: (2024-08-01)

Molecular diagnosis methods in familial hypercholesterolemia
by: Valeriu Moldovan, et al.
Published: (2020-02-01)

Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents
by: Aynur Küçükçongar Yavaş, et al.
Published: (2017-03-01)

SUBFRACTIONS OF ATHEROGENIC APOB-LIPOPROTEIDES IN PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
by: E. A. Utkina, et al.
Published: (2017-08-01)

Familial hypercholesterolemia mimicking juvenile idiopathic arthritis
by: Pooja Dhaon, et al.
Published: (2022-01-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte’s arginase activation
by: Gamaleldin I. Harisa, et al.
Published: (2017-01-01)

Diagnostic Characteristics of Familial Hypercholesterolemia in Children
by: Dinara I. Sadykova, et al.
Published: (2020-06-01)

EXPERIENCE WITH THE USE OF EVOLOCUMAB THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (IN KARELIA REPUBLIC)
by: V. A. Korneva, et al.
Published: (2020-06-01)

New insights into the management of homozygous familial hypercholesterolemia patients treated with lomitapide: a single-center experience
by: Gabriella Iannuzzo, et al.
Published: (2024-12-01)

Potential of Application of Natural Product Nanoparticles in Hypercholesterolemia
by: Laura M. Teixeira, et al.
Published: (2024-11-01)

Systematic review on effectiveness of flavonoids against hypercholesterolemia: Insights from in-silico, in-vitro, and in-vivo studies
by: Nurnazira Hanis, et al.
Published: (2025-06-01)

ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION
by: A. V. Kontsevaya, et al.
Published: (2018-07-01)

Coronary heart disease development in heterozygotic form of familial hypercholesterolemia
by: P. P. Malyshev, et al.
Published: (2006-10-01)

Hypercholesterolemia — as a marker of the study of nutritional behaviour in the elderly population
by: R. E. Chobanov, et al.
Published: (2021-07-01)

A clinical case of STEMI in a 19-year-old woman with hypercholesterolemia
by: S. Barakova, et al.
Published: (2024-12-01)

The impact of Kersen leaves (Muntingia calabura L.) extract on Mus musculus with hypercholesterolemia
by: Sion Benu, et al.
Published: (2024-08-01)

THE EFFECT OF GALLIC ACID AS PROTECTIVE AGENT ON SOME BIOCHEMICAL PARAMETERS INDUCED HYPERCHOLESTEROLEMIA IN LABORATORY MALE RATS
by: Muna F. Abass AL-Taei, et al.
Published: (2017-06-01)

Contribution of Rare and Common <i>APOE</i> Variants to Familial Hypercholesterolemia in Spanish Cohort
by: Lorena M. Vega-Prado, et al.
Published: (2025-01-01)

Ultrasound examination of achilles tendons in patients with familial hypercholesterolemia
by: V. V. Genkel, et al.
Published: (2018-09-01)

The effect of the fenugreek hydrolyzed protein on lipid profile in patients with mild-to-moderate hypercholesterolemia: A confirmatory triple-blind randomized-controlled clinical trial
by: Mahdi Badiee Gavarti, et al.
Published: (2025-02-01)

RUSSIAN GUIDELINES ON FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS AND TREATMENT
by: article Editorial
Published: (2017-06-01)

Modern ultrasound methods and atherosclerosis assessment in patients with familial hypercholesterolemia
by: A. I. Ershova, et al.
Published: (2011-06-01)

LIPOPROTEIN(A) MEANING AS AN ADDITIONAL MARKER OF CARDIOVASCULAR RISK IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2016-06-01)

Causal relationship between mental disorders and hypercholesterolemia： a Mendelian randomization analysis
by: Zou Qian, et al.
Published: (2025-04-01)

Prevalence of familial hypercholesterolemia and hyperlipoproteinemia(a) in patients with premature acute coronary syndrome
by: U. V. Chubykina, et al.
Published: (2022-07-01)